Cargando…
Influence of Ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet) - a prospective randomized controlled trial
PURPOSE: To demonstrate superiority of intravitreal ranibizumab 0.5 mg compared to focal and peripheral laser treatment in patients with radiation retinopathy for choroidal melanoma. METHODS: Inclusion criteria were as follows: patients with radiation retinopathy and visual acuity impairment due to...
Autores principales: | Seibel, Ira, Vollhardt, Daniela, Riechardt, Aline I., Rehak, Matus, Schmied, Sabine, Schiller, Petra, Zeitz, Oliver, Hellmich, Martin, Joussen, Antonia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575494/ https://www.ncbi.nlm.nih.gov/pubmed/32112140 http://dx.doi.org/10.1007/s00417-020-04618-7 |
Ejemplares similares
-
Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012) -
Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment
por: Gotz-Więckowska, Anna, et al.
Publicado: (2017) -
Combination therapy of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity
por: Dudani, Ajay I, et al.
Publicado: (2022) -
Efficacy of ranibizumab combined with photocoagulation for diabetic retinopathy: A meta-analysis study
por: Yin, Hongli, et al.
Publicado: (2023) -
Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
por: Xu, Yu, et al.
Publicado: (2016)